Kezar Life Sciences, Inc.
KZR
$4.09
$0.040.99%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -16.56M | -20.22M | -20.31M | -21.55M | -21.66M |
| Total Depreciation and Amortization | 251.00K | 259.00K | 260.00K | 261.00K | 260.00K |
| Total Amortization of Deferred Charges | 159.00K | 66.00K | 64.00K | 65.00K | 64.00K |
| Total Other Non-Cash Items | 2.09M | 2.40M | 1.96M | 3.25M | 1.92M |
| Change in Net Operating Assets | -3.14M | 668.00K | 536.00K | 945.00K | -3.45M |
| Cash from Operations | -17.19M | -16.83M | -17.49M | -17.03M | -22.86M |
| Capital Expenditure | -8.00K | -11.00K | -18.00K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 13.75M | 23.76M | 24.08M | 12.22M | 20.41M |
| Cash from Investing | 13.74M | 23.74M | 24.06M | 12.22M | 20.41M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.30M | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 47.00K | 0.00 | 56.00K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1.30M | 47.00K | 0.00 | 56.00K | -- |
| Foreign Exchange rate Adjustments | 5.00K | -75.00K | 16.00K | 3.00K | -7.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.75M | 6.89M | 6.58M | -4.76M | -2.46M |